Age
Item
adult patients, >=18 years of age
boolean
C0001779 (UMLS CUI [1])
Diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
Item
diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0521118 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0007117 (UMLS CUI [3,1])
C0332155 (UMLS CUI [3,2])
No significant physical abnormalities at the target basal cell carcinoma (e.g. tattoos)
Item
free of any significant physical abnormalities (e.g., tattoos) at the target basal cell carcinoma site
boolean
C0007117 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0449695 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Compliance and willingness for study site attendance
Item
willing and able to participate in the study as an outpatient and agreement to make frequent visits to the clinic during the treatment and follow-up periods and to comply with study requirements
boolean
C1321605 (UMLS CUI [1])
C0600109 (UMLS CUI [2,1])
C2825164 (UMLS CUI [2,2])
C2827364 (UMLS CUI [2,3])
Prior treatment with vismodegib
Item
prior treatment with vismodegib
boolean
C2987716 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
known hypersensitivity to any of the study drug excipients
Item
known hypersensitivity to any of the study drug excipients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0015237 (UMLS CUI [1,3])
Any metastatic basal cell carcinoma
Item
any metastatic basal cell carcinoma
boolean
C1304306 (UMLS CUI [1])
Inoperable basal cell carcinoma or contraindication to surgery
Item
any locally advanced basal cell carcinoma considered to be inoperable or to have a medical contraindication to surgery
boolean
C0007117 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0852649 (UMLS CUI [2])
Clinically significant and unstable diseases or conditions (e.g. cardiovascular, immunosuppressive, hematologic)
Item
evidence of clinically significant and unstable diseases or conditions (e.g., cardiovascular, immunosuppressive, hematologic)
boolean
C0009488 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0007222 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
C4048329 (UMLS CUI [3,1])
C0009488 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
C0750502 (UMLS CUI [3,4])
C0018939 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0750502 (UMLS CUI [4,3])
Any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
Item
any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
boolean
C0009488 (UMLS CUI [1,1])
C0037274 (UMLS CUI [1,2])
C0449695 (UMLS CUI [1,3])
Recent, current or planned participation in another experimental drug study
Item
recent, current, or planned participation in another experimental drug study
boolean
C2348568 (UMLS CUI [1])